Cincuenta años de investigación sobre el dolor y avances clínicos: aspectos destacados y tendencias clave: Publicado originalmente en la Revista Pain 2023; 164(11S): S11-S15.

Allan I. Basbaum; Troels S. Jensen; Francis J. Keefec

doi:10.47924/neurotarget2024468

Autores/as

Allan I. Basbaum Universidad de California San Francisco, San Francisco, CA, Estados Unidos.
Troels S. Jensen Centro Danés de Investigación del Dolor, Departamento de Medicina Clínica, Hospital de la Universidad de Aarhus, Aarhus N, Dinamarca.
Francis J. Keefec Centro Médico de la Universidad de Duke, Durham, Carolina del Norte, Estados Unidos.

DOI:

https://doi.org/10.47924/neurotarget2024468

Palabras clave:

Modelos animales, Sensibilización, Control de puertas, Terapia conductual, Psicometría, Opiáceos

Resumen

Este artículo destaca los avances en la investigación preclínica en ciencias básicas del dolor, la investigación clínica y la investigación psicológica que se han producido durante los 50 años transcurridos desde que se fundó la Asociación Internacional para el Estudio del Dolor. Presenta hallazgos importantes y tendencias clave en estas 3 áreas de la ciencia del dolor: investigación preclínica en ciencias básicas, investigación clínica e investigación psicológica.

Métricas

Cargando métricas ...

Citas

Akil H, Mayer DJ, Liebeskind JC. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science 1976;191:961–2.

Baron R, Fo¨ rster M, Binder A. Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol 2012;11:999–1005.

Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell 2009;139:267–84.

Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984;7:309–38.

Bender BJ, Gahbauer S, Luttens A, Lyu J, Webb CM, Stein RM, Fink EA, Balius TE, Carlsson J, Irwin JJ, Shoichet BK. A practical guide to largescale docking. Nat Protoc 2021;16:4799–832.

Bennett DL, Clark AJ, Huang J, Waxman SG, Dib-Hajj SD. The role of voltage-gated sodium channels in pain signaling. Physiol Rev 2019;99:1079–151.

Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. PAIN 1988;33:87–107.

Bernard JF, Bester H, Besson JM. Involvement of the spino-parabrachio-amygdaloid -hypothalamic-pathways in the autonomic and affective emotional aspects of pain. Prog Brain Res 1996;107:243–55.

Bradley LA, Prokop CK, Margolis R, Gentry WD. Multivariate analyses of the MMPI profiles of low back pain patients. J Behav Med 1978;1:253–72.

Cousins M, Mather L. Intrathecal and epidural administration of opioids. Anesthesiology 1984;61:276–310.

Crombie IK, Davies HTO, Macrae WA. The epidemiology of chronic pain: time for new directions. PAIN 1994;57:1–3.

Darnall BD. Psychological treatment for chronic pain: improving Access and integration. Psychol Sci Public Int 2021;22:45–51.

Davis KD, Flor H, Greely HT, Iannetti GD, Mackey S, Ploner M, Pustilnik A, Tracey I, Treede RD, Wager TD. Brain imaging tests for chronic pain: medical, legal and ethical issues and recommendations. Nat Rev Neurol 2017;13:624–38.

De Felice M, Eyde N, Dodick D, Dussor GO, Ossipov MH, Fields HL, Porreca F. Capturing the aversive state of cephalic pain preclinically. Ann Neurol 2013;74:257–65.

Eccleston C, Blyth FM, Dear BF, Fisher EA, Keefe FJ, Lynch ME, Palermo TM, Reid MC, Williams A. Managing patients with chronic pain during the COVID-19 outbreak: considerations for the rapid introduction of remotely supported (eHealth) pain management services. PAIN 2020;161:889–93.

Emery EC, Luiz AP, Wood JN. Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief. Expert Opin Ther Targets 2016;20:975–83.

Fink EA, Xu J,Hu¨ bner H, Braz JM, Seemann P, Avet C,Craik V,Weikert D, Schmidt MF, Webb CM, Tolmachova NA, Moroz YS, Huang XP, Kalyanaraman C, Gahbauer S, Chen G, Liu Z, Jacobson MP, Irwin JJ, BouvierM, Du Y, Shoichet BK, Basbaum AI, Gmeiner P. Structure-based discovery of nonopioid analgesics acting through the a2A-adrenergic receptor. Science 2022;377:eabn7065.

Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpaa M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. J Vasc Surg 2015;62:1091–173.

Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev 2021;101:259–301.

Flor H, Noguchi K, Treede R-D, Turk DC. The role of evolving concepts and new technologies and approaches in advancing pain research, management, and education since the establishment of the International Association for the Study of Pain. PAIN 2023;164:S16-S21.

Fordyce WE, Fowler RS, Lehmann JF, Delateur BJ, Sand PL, Trieschmann RB. Operant conditioning in the treatment of chronic pain. Arch Phys Med Rehabil 1973;54:399–408.

Ha¨ ring M, Zeisel A, Hochgerner H, Rinwa P, Jakobsson JET, Lo¨ nnerberg P, La Manno G, Sharma N, Borgius L, Kiehn O, Lagerstro¨m MC, Linnarsson S, Ernfors P. Neuronal atlas of the dorsal horn defines its architecture and links sensory input to transcriptional cell types. Nat Neurosci 2018;21:869–80.

Headache Classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia 2018; 38:1–211.

Holroyd KA, Nash JM, Pingel JD, Cordingley GE, Jerome A. A comparison of pharmacological (Amitriptyline HCL) and nonpharmacological (cognitivebehavioral) therapies for chronic tension headaches. J ConsultClin Psychol 1991;59:387–93.

Holroyd KA, Penzien DB, Hursey KG, Tobin DL, Rogers L, Holm JE, Marcille PJ, Hall JR, Chila AG. Change mechanisms in EMG biofeedback training: cognitive changes underlying improvements in tensión headache. J Consult Clin Psychol 1984;52:1039–53.

Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975;258:577–9.

Iyer SM, Vesuna S, Ramakrishnan C, Huynh K, Young S, Berndt A, Lee SY, Gorini CJ, Deisseroth K, Delp SL. Optogenetic and chemogenetic strategies for sustained inhibition of pain. Sci Rep 2016;6:30570.

Keefe FJ, Shelby RA, Somers TJ, Varia I, BlazingM, Waters SJ, McKee D, Silva S, She L, Blumenthal JA, O’Connor J, Knowles V, Johnson P, Bradley L. Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized-controlled study. PAIN 2011;152:730–41.

Kehlet H. Postoperative pain, analgesia, and recovery-bedfellows that cannot be ignored. PAIN 2018;159:S11–6.

Kieffer BL, Evans CJ. Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 2009;56(suppl 1):205–12.

Knotkova H, Hamani C, Sivanesan E, Le Beuffe MFE, Moon JY, Cohen SP, Huntoon MA. Neuromodulation for chronic pain. Lancet 2021;397:2111–24.

Kuhn JA, Vainchtein ID, Braz J, Hamel K, Bernstein M, Craik V, Dahlgren MW, Ortiz-Carpena J, Molofsky AB,Molofsky AV, BasbaumAI. Regulatory T-cells inhibit microglia-induced pain hypersensitivity in female mice. Elife 2021;10:e69056.

Labau JIR, Andelic M, Faber CG, Waxman SG, Lauria G, Dib-Hajj SD. Recent advances for using human induced-pluripotent stem cells as painin-a-dish models of neuropathic pain. Exp Neurol 2022;358:114223.

Langford DJ, Bailey AL, Chanda ML, Clarke SE, Drummond TE, Echols S, Glick S, Ingrao J, Klassen-Ross T, Lacroix-Fralish ML, Matsumiya L, Sorge RE, Sotocinal SG, Tabaka JM, Wong D, van den Maagdenberg AM, Ferrari MD, Craig KD, Mogil JS. Coding of facial expressions of pain in the laboratory mouse. Nat Methods 2010;7:447–9.

Ledford H, Callaway E. Medicine Nobel goes to scientists who discovered biology of senses. Nature 2021;598:246.

Malmberg AB, Yaksh TL. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci 1994;14:4882–90.

McQuay HJ, Moore RA. An evidence-based resource for pain relief. Oxford, United Kingdom: Oxford University Press, 1998.

Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. PAIN 1975;1:277–99.

Messina R, Goadsby PJ. CGRP—a target for acute therapy in migraine: clinical data. Cephalalgia 2019;39:420–27.

Mitchell KR, White RG. Behavioral self-management: an application to the problem of migraine headaches. Behav Ther 1977;8:213–21.

Moont R, Pud D, Sprecher E, Sharvit G, Yarnitsky D. “Pain inhibits pain” mechanisms: is pain modulation simply due to distraction? PAIN 2010;150:113–20.

Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004;350:1104–10.

Sternbach R. Pain patients: traits and treatments. New York: Academic Press, 1974.

Stone AA, Obbarius A, Junghaenel DU, Wen CKF, Schneider S. High resolution, field approaches for assessing pain: ecological momentary assessment. PAIN 2021;162:4–9.

Tavares-Ferreira D, Shiers S, Ray PR, Wangzhou A, Jeevakumar V, Sankaranarayanan I, Cervantes AM, Reese JC, Chamessian A, Copits BA, Dougherty PM, Gereau RW IV, Burton MD, Dussor G, Price TJ. Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors. Sci Transl Med 2022;14:eabj8186.

Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavand’homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International Classification of Diseases (ICD-11). PAIN 2019;160:19 27.

Turk DC, Meichenbaum D, Genest M. Pain and behavioral medicine: a cognitive-behavioral perspective. New York: Guilford, 1983.

Turner JA. Comparison of group progressive-relaxation training and cognitive-behavioral group therapy for chronic low back pain. J Consult Clin Psychol 1982;50:757–65.

Urban DJ, Roth BL. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu Rev Pharmacol Toxicol 2015;55:399–417.

Usoskin D, Furlan A, Islam S, Abdo H, Lo¨ nnerberg P, Lou D, Hjerling-Leffler J, Haeggstro¨m J, Kharchenko O, Kharchenko PV, Linnarsson S, Ernfors P. Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing. Nat Neurosci 2015;18:145- 53.

Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemiologic comparison of pain complaints. PAIN 1988;32:173–83.

Williams AC dC, Richardson PH, Nicholas MK, Pither CE, Harding VR, Ridout KL, Ralphs JA, Richardson IH, Justins DM, Chamberlain JH. Inpatient vs. outpatient pain management: results of a randomised controlled trial. PAIN 1996;66:13–22.

Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983;306:686–8.

Woolf CJ, Bennett GJ, Doherty M, Dubner R, Kidd B, Koltzenburg M, Lipton R, Loeser JD, Payne R, Torebjork E. Towards a mechanism-based classification of pain? PAIN 1998;77:227–9.

Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976;192:1357–8.